Critical Healthcare Ltd

criticalhealthcare.com

Critical Healthcare Ltd strives to be the 1st Choice of Emergency Medical Professionals. It offers a comprehensive range of medical products and services to the pre-hospital market, fire services and ambulance providers in Ireland, the UK and Europe.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MedTech, Industry Outlook

MISSION BIO LAUNCHES TAPESTRI V3 TO RAPIDLY ACCELERATE RARE CELL DETECTION APPLICATIONS FOR TRANSLATIONAL RESEARCH AND PRECISION THERAPEUTICS

PRNewswire | June 01, 2023

news image

Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced breakthrough improvements to the Tapestri® Platform and its core chemistry that enable highly confident detection of rare cells for a range of applications. With Tapestri® v3 chemistry, researchers can discover tiny numbers of single cells that, until now, easily escaped detection and influenced disease in invisible ways. At the same time, drug developers can use the new capabiliti...

Read More

Cell and Gene Therapy, Medical

SYNTHEGO AND BIT.BIO EXPAND STRATEGIC PARTNERSHIP TO BUILD A PLATFORM FOR THE DEVELOPMENT OF SAFER AND MORE EFFICIENT GENETIC ENGINEERING OF HUMAN

prnewswire | August 25, 2023

news image

Synthego, a leading provider of industrialized genome editing solutions that accelerate discovery to clinic journey, and bit.bio, the company coding human cells for novel cures, today announced a strategic partnership to build a platform centered on the implementation of synthetic circuitry in cells for therapeutic application. bit.bio is building a pipeline of cell therapies focused on areas of unmet clinical need. The partnership will apply Synthego's expertise in gene edi...

Read More

Cell and Gene Therapy, Industrial Impact

CBM ANNOUNCES PARTNERSHIP WITH VIRION THERAPEUTICS

Center for Breakthrough Medicines | February 27, 2023

news image

Center for Breakthrough Medicines (CBM), a leading contract development and manufacturing organization dedicated to addressing the challenges of commercializing cell and gene therapies, and Virion Therapeutics, a clinical-stage biotech firm focused on developing accessible and adaptable CD8+ T cell-based technologies for cancer and infectious diseases, have recently announced a strategic collaboration agreement. CBM will partner and manufacture with Virion Therapeutics on their ...

Read More

Cell and Gene Therapy

KITE AND SHORELINE BIOSCIENCES FORM STRATEGIC PARTNERSHIP TO DEVELOP NOVEL ALLOGENEIC CELL THERAPIES

Kite, Shoreline Biosciences | June 18, 2021

news image

Kite, a Gilead Company, and Shoreline Biosciences, Inc., a biotechnology firm developing intelligently designed allogeneic off-the-shelf, standardized, and targeted natural killer (NK) and Macrophage cellular immunotherapies achieved from induced pluripotent stem cells (iPSC) for cancer and other serious diseases, announced a strategic partnership today to develop novel cell therapies across a variety of indications. The collaboration will combine Shoreline’s profound experi...

Read More
news image

MedTech, Industry Outlook

MISSION BIO LAUNCHES TAPESTRI V3 TO RAPIDLY ACCELERATE RARE CELL DETECTION APPLICATIONS FOR TRANSLATIONAL RESEARCH AND PRECISION THERAPEUTICS

PRNewswire | June 01, 2023

Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced breakthrough improvements to the Tapestri® Platform and its core chemistry that enable highly confident detection of rare cells for a range of applications. With Tapestri® v3 chemistry, researchers can discover tiny numbers of single cells that, until now, easily escaped detection and influenced disease in invisible ways. At the same time, drug developers can use the new capabiliti...

Read More
news image

Cell and Gene Therapy, Medical

SYNTHEGO AND BIT.BIO EXPAND STRATEGIC PARTNERSHIP TO BUILD A PLATFORM FOR THE DEVELOPMENT OF SAFER AND MORE EFFICIENT GENETIC ENGINEERING OF HUMAN

prnewswire | August 25, 2023

Synthego, a leading provider of industrialized genome editing solutions that accelerate discovery to clinic journey, and bit.bio, the company coding human cells for novel cures, today announced a strategic partnership to build a platform centered on the implementation of synthetic circuitry in cells for therapeutic application. bit.bio is building a pipeline of cell therapies focused on areas of unmet clinical need. The partnership will apply Synthego's expertise in gene edi...

Read More
news image

Cell and Gene Therapy, Industrial Impact

CBM ANNOUNCES PARTNERSHIP WITH VIRION THERAPEUTICS

Center for Breakthrough Medicines | February 27, 2023

Center for Breakthrough Medicines (CBM), a leading contract development and manufacturing organization dedicated to addressing the challenges of commercializing cell and gene therapies, and Virion Therapeutics, a clinical-stage biotech firm focused on developing accessible and adaptable CD8+ T cell-based technologies for cancer and infectious diseases, have recently announced a strategic collaboration agreement. CBM will partner and manufacture with Virion Therapeutics on their ...

Read More
news image

Cell and Gene Therapy

KITE AND SHORELINE BIOSCIENCES FORM STRATEGIC PARTNERSHIP TO DEVELOP NOVEL ALLOGENEIC CELL THERAPIES

Kite, Shoreline Biosciences | June 18, 2021

Kite, a Gilead Company, and Shoreline Biosciences, Inc., a biotechnology firm developing intelligently designed allogeneic off-the-shelf, standardized, and targeted natural killer (NK) and Macrophage cellular immunotherapies achieved from induced pluripotent stem cells (iPSC) for cancer and other serious diseases, announced a strategic partnership today to develop novel cell therapies across a variety of indications. The collaboration will combine Shoreline’s profound experi...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us